69 Biotech Startups in London to Watch in 2024
How do we build this list?
Tracking:
Last update to the database: April 9, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
AI platform to map the human immune system. |
$14M · Series A | Life Extension Ventures, Molten Ventures | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@imubiosciences.com | ||
Oophthalmic gene therapy company to treat blinding retinal illnesses. |
$120M · Series A | Syncona Partners LLP | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@beacontx.com | ||
Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies. |
$8M · Series A | Mercia Asset Management | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@mipdiscovery.com | ||
AI vaccine algorithm developer. |
$11M · Series A | Hoxton Ventures, Merck Global Health Innovation Fund, Cherry Ventures | 1 to 10 | AI, Biotech | B2B, SaaS | London, UK | •••••••••••@baseimmune.co.uk | |
Biomedical research discovery tool. |
$60M · Series B | ICONIQ Growth, Index Ventures, Pentech Ventures | 51 to 100 | Health Tech, AI, Biotech, Pharma | B2B, SaaS | London, UK | •••••••••••@causaly.com | |
Portfolio of pharmaceutical research and discovery. |
$33M · Series C | Patient Square Capital, Rock Springs Capital, M&G Investments | 1 to 10 | Biotech, Pharma | London, UK | •••••••••••@apollotherapeutics.com | ||
Developer of sustainable plant-based pigments. |
$3M · Seed | PDS Ventures, Circular Innovation Fund, L'Oreal | 1 to 10 | Biotech, Manufacturing | B2C | London, UK | •••••••••••@sparxell.com | |
Discovery and development platform of superior microbial bioproducts. |
$6M · Series A | Pymwymic, Clean Growth Fund | 1 to 10 | Biotech | London, UK | •••••••••••@fungialert.com | ||
Fully-automated cell manufacturing. |
$19M · Series A | Buckley Ventures, Wing Venture Capital, IQ Capital Partners | 11 to 50 | Biotech, Machine Learning | B2B | London, UK | •••••••••••@mytos.bio | |
Preclinical stage treatment for geographic atrophy. |
$78M · Series A | Forbion Capital Partners, Gimv | 1 to 10 | Biotech | London, UK | •••••••••••@complementtx.com | ||
Neuroscience-driven AI platform. |
$2M · Seed | Rockmount Capital, UCL Technology Fund, Moonfire Ventures | 11 to 50 | AI, Biotech | B2B, SaaS | London, UK | •••••••••••@stanhopeai.com | |
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits. |
$28M · Series B | Future Planet Capital | 11 to 50 | Agritech, Biotech, Deep Tech, Manufacturing | B2B | London, UK | •••••••••••@tropicbioscience.com | |
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. |
$25M | Kindred Capital, Atomico | 51 to 100 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@labgeni.us | |
ReViral is a biotechnology company that develops and offers antiviral therapies for patients. |
$44M · Series C | Novo A/S, Andera Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@reviral.co.uk | |
Quell Therapeutics is a cell therapy company |
$45M · Series A | AlbionVC, Point72 Ventures | 101 to 250 | Health Tech, Edtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@quell-tx.com | |
Cancer treatment predictor software. |
$14M · Series A | Hoxton Ventures, Octopus Ventures, Fly Ventures | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@pearbio.com | |
Clinical trials platform. |
$18M · Series A | Valar Ventures, Seedcamp, Atomico | 11 to 50 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@lindushealth.com | |
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. |
$30M · Series A | Kindred Capital, Octopus Ventures, Amadeus Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@oribiotech.com | |
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins. |
$50M · Series A | General Catalyst, Khosla Ventures | 1 to 10 | Health Tech, AI, Biotech, Data and Analytics | B2B | London, UK | •••••••••••@charmtx.com | |
AI-powered drug testing platform. |
$1M · Pre Seed | Seedcamp, Episode 1 | 1 to 10 | AI, Biotech | London, UK | •••••••••••@sablebio.com | ||
3D human lung model developer. |
$2M · Seed | Pioneer Group, Mercia Asset Management, Midlands Engine Investment Fund | 11 to 50 | Biotech, Deep Tech | London, UK | •••••••••••@immuone.com | ||
Gene silencing platform for the creation of programmable, allogeneic cell therapies. |
$16M · Seed | Mercia Asset Management, Calculus Capital, UK Innovation & Science Seed Fund | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@laverocktx.com | ||
User-owned genomics database platform. |
$20M · Series A | GEM Digital | 1 to 10 | Health Tech, Biotech | B2C | London, UK | •••••••••••@genomes.io | |
Patent-protected anti-inflammatory painkiller. |
$6M · Series A | ITV AdVentures | 1 to 10 | Biotech, Pharma | B2C | London, UK | •••••••••••@flarin.co.uk | |
Platform to automate the clinical studies process. |
$12M · Series A | Playfair, Delin Ventures, 11.2 Capital | 11 to 50 | Health Tech, Biotech | B2B | London, UK | •••••••••••@umed.io | |
Precision therapeutics discovery platform. |
$6M · Seed | Hoxton Ventures | 11 to 50 | Biotech | B2B | London, UK | •••••••••••@multiomic.uk | |
Precision software for eye surgery. |
$8M · Seed | Redalpine | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@hypervisionsurgical.com | ||
Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. |
$17M · Seed | AlbionVC, Boxer Capital, Syncona Partners LLP | 101 to 250 | Health Tech, Biotech | B2B | London, UK | •••••••••••@achillestx.com | |
Daye is a gynecological health company that creates products and services for vaginal treatment. |
$5M · Seed | Index Ventures, Khosla Ventures, Kindred Capital | 11 to 50 | Health Tech, Biotech, Manufacturing, Ecommerce, Cannabis | B2C | London, UK | •••••••••••@yourdaye.com | |
Quantum simulation platform for drug discovery. |
$2M · Seed | Ascension Ventures, ACF Investors | 1 to 10 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@kuano.ai | |
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors. |
$6M · Seed | Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@myricxpharma.com | |
OpenCell builds biotech labs in shipping containers with the aim of making biotechnology accessible and affordable. |
$8M | Seventure Partners | 1 to 10 | Fintech, Biotech, Proptech & Real Estate, Manufacturing | B2B, SaaS | London, UK | •••••••••••@opencell.bio | |
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure. |
$11M · Series A | Business Growth Fund, Deepbridge Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@pathfindermed.com | |
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies. |
$10M | Y Combinator, Pi Campus | 11 to 50 | Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence | B2B | London, UK | •••••••••••@sixfold.bio | |
Digital-twin simulator. |
$3M · Pre Seed | Crane Venture Partners | 1 to 10 | Biotech, Supply Chain & Logistics | B2B | London, UK | •••••••••••@quaisr.io | |
Protein discovery research and manufacturing. |
$19M · Series A | SYSTEMIQ | 11 to 50 | Biotech, Deep Tech | London, UK | •••••••••••@basecamp-research.com | ||
At-home fertility treatment. |
$3M · Seed | Octopus Ventures, Calm/Storm Ventures, QVentures | 1 to 10 | Health Tech, Biotech | B2C | London, UK | •••••••••••@beafertility.com | |
Immunotherapy for the treatment of cancer. |
$1M · Seed | Cancer Research Horizons, UK Innovation & Science Seed Fund | 11 to 50 | Biotech, Pharma | B2C | London, UK | •••••••••••@nk-io.com | |
Developer of drugs to treat respiratory diseases. |
$2M · Series A | Versant Ventures, Forbion Capital Partners, Imperial Innovations | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@enterprisetherapeutics.com | ||
Cell-free chemical manufacturer to produce bio-based alternatives |
$3M · Seed | Hoxton Ventures, Atomico, BACKED VC | 11 to 50 | Biotech | B2B | London, UK | •••••••••••@fabricnano.com | |
Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint. |
$4M | Octopus Ventures, Ascension Ventures, Metaplanet Holdings | 11 to 50 | Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@foodsteps.earth | |
Computer simulation to understand drug-bacteria interactions. |
$5M · Seed | Hoxton Ventures, Sofinnova Partners | 1 to 10 | Biotech | London, UK | •••••••••••@biocortex.co.uk | ||
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins. |
$2M | Hoxton Ventures, Bessemer Venture Partners | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | London, UK | •••••••••••@peptone.io | |
Developer of novel Treg therapies to treat inflammatory disorders. |
$840k · Pre Seed | Deep Science Ventures, Wren Capital | 1 to10 | Health Tech, Biotech | B2C | London, UK | •••••••••••@bastion-tx.com | |
Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water |
$3M · Seed | Kindred Capital, Verve Ventures | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing | B2B | London, UK | •••••••••••@puraffinity.com | |
Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals. |
$3M · Pre Seed | Lowercarbon Capital, Ascension Ventures, BoxGroup | 11 to 50 | Biotech, Manufacturing | B2B | London, UK | •••••••••••@epochbiodesign.com | |
Based in London, UK, Hoxton Farms is growing cultivated fat as an ingredient for the meat alternatives industry. |
$3M · Seed | BACKED VC, CPT Capital | 11 to 50 | Foodtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@hoxtonfarms.com | |
Building the future of food, starting with dairy. |
$2M · Seed | Entrepreneur First, Vorwerk Ventures, Redalpine | 1 to 10 | Agritech, Foodtech, Biotech, Manufacturing | B2B, B2C | London, UK | •••••••••••@betterdairy.co.uk | |
Immuno-oncology company treats cancer with antibodies. |
$2M · Series A | AlbionVC, Novartis Venture Fund, Epidarex Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics | B2B | London, UK | •••••••••••@epsilogen.com | |
Developer of cutting-edge DNA techniques to monitor biodiversity. |
$3M · Seed | SYSTEMIQ, BNP Paribas, Green Angel Ventures | 11 to 50 | Biotech | London, UK | •••••••••••@naturemetrics.co.uk | ||
Arborea is industrialising photosynthesis to expand the world’s food supply |
$4M · Seed | Business Growth Fund | 1 to 10 | Climate Tech & Green Tech, Foodtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@arborea.io | |
Gene and cell therapy manufacturing. |
$65M · Series A | 11 to 50 | Biotech | London, UK | •••••••••••@ascend-gctx.com | |||
Gardin develops optical phenotyping technology and analytics to optimise food production. |
$1M · Pre Seed | Seedcamp, Molten Ventures, MMC Ventures | 11 to 50 | Agritech, Foodtech, Biotech, Data and Analytics | B2B, SaaS | London, UK | •••••••••••@gardin.co.uk | |
Developer of innovative treatment for muscle wasting disorders. |
$1M · Seed | Mankind Pharma | 1 to 10 | Biotech, Pharma | London, UK | •••••••••••@actimedtherapeutics.com | ||
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening. |
$104k · Pre Seed | Atomico, Entrepreneur First | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics | B2B | London, UK | •••••••••••@exogene.co.uk | |
LiliumX discovers new bispecific antibodies against cancer by utilizing a protein technology platform to facilitate the scalable discovery. |
$125k · Pre Seed | Hoxton Ventures, Y Combinator | 1 to 10 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@liliumx.com | |
Biomedical CloudOS data platform. |
$120k · Seed | Eurazeo, Connect Ventures, Techstars | 51 to 100 | Health Tech, Biotech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@lifebit.ai | |
Sequential Skin is improving human health with the world's first skin microbiome test for consumers and companies. |
$500k · Pre Seed | Metaplanet Holdings | 11 to 50 | Health Tech, Fashion, Biotech | B2B | London, UK | •••••••••••@sequentialskin.com | |
Shellworks is a biotech startup on a mission to make plastic waste a thing of the past. |
$820k · Pre Seed | Local Globe, Atomico, Ascension Ventures | 1 to 10 | Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing, Supply Chain & Logistics | B2B | London, UK | •••••••••••@theshellworks.com | |
One lab management platform that brings people, equipment and data together - no matter where they are. |
$1M | Forward Partners | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@clustermarket.com | |
Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies. |
$125k · Pre Seed | Y Combinator | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | London, UK | •••••••••••@nuntiustx.com | |
Syrona Health is a personalised digital health platform for Chronic Gynaecological/Uterine Conditions like Endometriosis, PCOS etc. |
$253k · Seed | Y Combinator, Katapult Accelerator | 1 to 10 | Health Tech, Biotech, Deep Tech, Femtech, Ecommerce, ElderTech, Fertility | B2B | London, UK | •••••••••••@syronahealth.com | |
Neucruit is transforming the efficiency, transparency and diversity of clinical trials |
$100k · Pre Seed | Atomico, Nina Capital | 11 to 50 | Health Tech, Biotech, Hiring and Recruitement, Data and Analytics, Community & Lifestyle, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@neucruit.com | |
Concert Bio helps businesses create optimal microbial communities. |
$1M · Pre Seed | Nucleus Capital | 1 to 10 | Agritech, Biotech, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@concert.bio | |
Digistain uses infrared scanning to determine which breast cancer patients are fit for chemotherapy. |
$125k · Pre Seed | Y Combinator | 1 to 10 | Health Tech, Hardware, Biotech, Manufacturing | B2B | London, UK | •••••••••••@digistain.co.uk | |
Emm is developing the next generation of bio-wearables for better healthcare |
$1M | Innovate UK | 1 to 10 | Biotech | London, UK | •••••••••••@emm.co | ||
AI-powered bioengineering platform to develop eco-friendly substitutes to every day materials. |
$610k · Seed | Seedcamp, Project A Ventures, Creative UK | 1 to 10 | Biotech, Machine Learning | London, UK | •••••••••••@twig.bio | ||
Bluezone Insurance offers personalized, same-day life cover for people with chronic conditions, like type 2 diabetes and heart diseases. |
$1M · Seed | Insurtech Gateway, Portfolio Ventures | 1 to 10 | Health Tech, Fintech, Biotech, Deep Tech, Insuretech | B2C | London, UK | •••••••••••@bluezoneinsurance.co.uk | |
dnaNUDGE aims to nudge people towards a better lifestyle based on their DNA. |
$60M · Series A | 11 to 50 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@dnanudge.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.